
Hepaticogastrostomy versus choledochoduodenostomy: An international multicenter study on their long-term patency
Author(s) -
Amy Tyberg,
Bertrand Napoléon,
Carlos Robles-Medranda,
Janak N. Shah,
Erwan Bories,
Nikhil A. Kumta,
Andrés Sánchez Yagüe,
Enrique Vazquez-Sequeiros,
Sundeep Lakhtakia,
Abdul Hamid El Chafic,
Shawn L. Shah,
Sohini Sameera,
Augustine Tawadros,
José Celso Ardengh,
Prashant Kedia,
Monica Gaidhane,
Marc Giovannini,
Michel Kahaleh
Publication year - 2022
Publication title -
endoscopic ultrasound
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.883
H-Index - 24
eISSN - 2303-9027
pISSN - 2226-7190
DOI - 10.4103/eus-d-21-00006
Subject(s) - medicine , endoscopic retrograde cholangiopancreatography , demographics , stent , adverse effect , bile duct , intrahepatic bile ducts , jaundice , surgery , decompression , gastroenterology , pancreatitis , demography , sociology
EUS-guided biliary drainage (EUS-BD) offers minimally invasive decompression when conventional endoscopic retrograde cholangiopancreatography fails. Stents can be placed from the intrahepatic ducts into the stomach (hepaticogastrostomy [HG]) or from the extrahepatic bile duct into the small intestine (choledochoduodenostomy [CCD]). Long-term patency of these stents is unknown. In this study, we aim to compare long-term patency of CCD versus HG.